Products listed may not be available in all markets. To find out if a product is available in your region, please contact us.

All Products

GORE ACUSEAL Vascular Graft

GORE® ACUSEAL Vascular Graft

The GORE® ACUSEAL Vascular Graft allows for earlier removal or avoidance of a central venous catheter (CVC), providing an alternative for your hemodialysis patients.

GORE INTERING Vascular Graft

GORE® INTERING® Vascular Graft

The GORE® INTERING® Vascular Graft is designed for surgical bypass or vascular access with a reduction in trauma and complications associated with external reinforcement.

GORE PROPATEN Vascular Graft

GORE® PROPATEN® Vascular Graft

Addressing the problem of thrombus formation on the luminal surface of a vascular graft is a challenge faced by all vascular surgeons. The GORE® PROPATEN® Vascular Graft is specifically designed for those vascular procedures in which the risk of acute graft thrombotic failure is of clinical concern.

GORE-TEX Stretch Vascular Graft For Vascular Access

GORE-TEX® Stretch Vascular Graft For Vascular Access

GORE-TEX® Vascular Graft has long been the prosthetic of choice among vascular surgeons worldwide.

GORE-TEX Suture

GORE-TEX® Suture

The GORE-TEX® Suture is a microporous, monofilament suture of flexible biomaterial for excellent handling, reduced hole-leakage, and minimal irritation in soft tissue approximation.

GORE VIABAHN Endoprosthesis

GORE® VIABAHN® Endoprosthesis

Proven across a broad range of complex cases, the versatility of the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface*,† enables you to deliver high patency and durable outcomes to minimize interventions for your patients.

GORE VIABAHN VBX Balloon Expandable Endoprosthesis

GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis

Products are not currently available in all markets.

Designed to expand to every demand, the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) offers the proven procedural success and long-term outcomes through flexibility, strength, and accuracy to treat aortoiliac occlusive disease.